Klaus is a Partner and member of the senior leadership team at ClearView, with broad experience across the biopharmaceutical value chain. He has diverse expertise in corporate strategy and transformation, therapeutic area, disease and asset-level growth strategies as well as go-to-market and launch excellence. He led strategic engagements across a broad range of therapeutic areas, primary and specialty care. His work spans biotechs, mid-sized and large biopharmas as well as pharmacy and hospital chains.
Klaus has over 12 years of experience within life science consulting. Prior to ClearView, Klaus served as a partner at Boston Consulting Group driving the commercial strategy business.
He received his MD and Ph.D. from University of Regensburg (Germany) and gained practical experience at the Swiss Olympic Medical Center in Zurich (Switzerland). Klaus also holds a M.Sc. in Drug Research and Management from the University of Berlin, a B.Sc. in Business Administration from the University of Regensburg, and a diploma in Health Economics from European Business School Östrich-Winkel.
Debbi Amanti Belanger